| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/13/2009 | WO2009073517A3 Intravesical compositions with valrubicin for the treatment of bladder cancer |
| 08/13/2009 | WO2009073508A3 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 08/13/2009 | WO2009047800A3 Oral controlled release composition of carvedilol |
| 08/13/2009 | WO2009047434A3 Use of carriers as preservatives and pharmaceutical composition containing same |
| 08/13/2009 | WO2009046444A3 Formulation for intranasal administration of diazepam |
| 08/13/2009 | WO2009019662A3 Oral metaxalone compositions |
| 08/13/2009 | WO2009019294A3 Bupropion hydrobromide and therapeutic applications |
| 08/13/2009 | WO2009013594A3 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 08/13/2009 | WO2009005798A3 Antifungal formulation and method of preparation |
| 08/13/2009 | WO2008148742A3 Pharmaceutical formulation for the production of rapidly disintegrating tablets |
| 08/13/2009 | WO2008140507A8 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| 08/13/2009 | WO2008140475A3 Imaging contrast agents using nanoparticles |
| 08/13/2009 | WO2008098364A8 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/13/2009 | WO2008073448A3 Pharmaceutical formulations and methods for making the same |
| 08/13/2009 | WO2008035229A3 Compositions and methods for ph targeted drug delivery |
| 08/13/2009 | US20090204104 Methods for Compounding and Delivering a Therapeutic Agent to the Adventitia of a Vessel |
| 08/13/2009 | US20090203799 Novel compositions comprising carotenoids |
| 08/13/2009 | US20090203798 Solid Pharmaceutical Compositions Comprising a SIP Receptor Agonist and a Sugar Alcohol |
| 08/13/2009 | US20090203792 Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators |
| 08/13/2009 | US20090203777 Organic compounds |
| 08/13/2009 | US20090203768 Nucleic acid-containing complex |
| 08/13/2009 | US20090203748 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| 08/13/2009 | US20090203660 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 08/13/2009 | US20090203648 Modified phosphocalcic compound, injectable composition containing same |
| 08/13/2009 | US20090203621 Tripeptides that Down Regulate the Activity of Plasma Membrane transporters Including Sodium-D-Glucose Cotransporter Sglt1 |
| 08/13/2009 | US20090203576 Methods and compositons for pulmonary delivery of insulin |
| 08/13/2009 | US20090202654 Skin Care Compositions and Treatments |
| 08/13/2009 | US20090202652 Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof |
| 08/13/2009 | US20090202651 Antigen specific fluorescent nanoparticles |
| 08/13/2009 | US20090202650 Methods of treating cancers |
| 08/13/2009 | US20090202649 Fenofibrate formulations |
| 08/13/2009 | US20090202647 Solid form of racemic rotigotine |
| 08/13/2009 | US20090202646 Method For Preparing Nano-Scale Particle of Active Material |
| 08/13/2009 | US20090202645 Intrasynovial formulations of stanozolol |
| 08/13/2009 | US20090202644 Functional nanoparticle filled carbon nanotubes and methods of their production |
| 08/13/2009 | US20090202643 Oil-in-water emulsions containing lignan-class compounds and compositions containing the same |
| 08/13/2009 | US20090202642 Drug Delivery System Comprising Microparticles and Gelation System |
| 08/13/2009 | US20090202641 Hollow fibrous organic nanotube and production method thereof |
| 08/13/2009 | US20090202640 Hydrogels of polysaccharide mixtures for tissue engineering and as carriers of active compounds |
| 08/13/2009 | US20090202639 Biomaterials Consisting of Sulphated Hyaluronic Acid and Gellan to be Used in the Prevention of Spinal Adhesions |
| 08/13/2009 | US20090202638 Bmp gene and fusion protein |
| 08/13/2009 | US20090202637 Oral pharmaceutical coated composition for pulsatile release |
| 08/13/2009 | US20090202636 Pharmaceutical Composition |
| 08/13/2009 | US20090202635 Delivery System, Application, and Method |
| 08/13/2009 | US20090202634 Pharmaceutical dosage form |
| 08/13/2009 | US20090202633 Extended release formulations of guaifenesin |
| 08/13/2009 | US20090202632 Sublingual Buccal Effervescent |
| 08/13/2009 | US20090202631 Methods and dosage forms for controlled delivery of paliperidone and risperidone |
| 08/13/2009 | US20090202630 Orally disintegrating tablet compositions of ranitidine and methods of manufacture |
| 08/13/2009 | US20090202629 Controlled release hydrocodone formulations |
| 08/13/2009 | US20090202628 Nanoparticles for protein drug delivery |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202626 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | US20090202625 Trypanosome microsome system and uses thereof |
| 08/13/2009 | US20090202624 Method for detecting carcinoma and agent for suppressing carcinoma |
| 08/13/2009 | US20090202623 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent |
| 08/13/2009 | US20090202622 Virosome-like vesicles comprising gp41-derived antigens |
| 08/13/2009 | US20090202621 Cell-surface decoration with active agents |
| 08/13/2009 | US20090202620 Polymer-stabilized liposomal compositions and methods of use |
| 08/13/2009 | US20090202619 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/13/2009 | US20090202618 Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases |
| 08/13/2009 | US20090202617 Gas based wound and tissue therapeutics |
| 08/13/2009 | US20090202616 Composite, Method of Producing the Composite and Uses of the Same |
| 08/13/2009 | US20090202615 Compositions for Treating Biofilms and Methods for Using Same |
| 08/13/2009 | US20090202614 Methods for stepwise deposition of silk fibroin coatings |
| 08/13/2009 | US20090202613 Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same |
| 08/13/2009 | US20090202611 Composite self-cohered web materials |
| 08/13/2009 | US20090202608 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/13/2009 | US20090202607 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 08/13/2009 | US20090202605 High aspect ratio template and method for producing same for central and peripheral nerve repair |
| 08/13/2009 | US20090202601 Method for inhibiting onset of or treating pollen allergy |
| 08/13/2009 | US20090202597 Ache-Nmda Combination Wafer |
| 08/13/2009 | US20090202596 Pharmaceutical compositions with biological barriers permeation enhancing properties |
| 08/13/2009 | US20090202575 Immunostimulatory nucleic acid molecules |
| 08/13/2009 | US20090202447 Inhalant aerosol formulations containing ethanol |
| 08/13/2009 | US20090202446 Microemulsion composition for air freshener |
| 08/13/2009 | US20090202445 Composition of a liquid dietary supplement to treat symptoms of autism spectrum disorders in children. |
| 08/13/2009 | US20090202444 Treatment and prevention of systemic Xylella fastidiosa infections of plants using antimicrobial metal compositions |
| 08/13/2009 | US20090202433 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 08/13/2009 | US20090202430 Composition for cytocompatible, injectable, self-gelling polysaccharide solutions for encapsulating and delivering live cells or biologically active factors |
| 08/13/2009 | US20090200392 Device for spraying a cosmetic composition while blowing hot or cold air |
| 08/13/2009 | DE202008008532U1 Lutschzusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Sucking composition for the treatment of inflammatory diseases of the mouth and throat |
| 08/13/2009 | DE112007002330T5 Mikrokapselblatt Microcapsule sheet |
| 08/13/2009 | DE102008008522A1 Implantierbare Nanopartikel-enthaltende Produkte Implantable nanoparticle-containing products |
| 08/13/2009 | CA2724230A1 Platinum aggregates and process for producing the same |
| 08/13/2009 | CA2714972A1 Use of p27kip1 for the prevention and treatment of heart failure |
| 08/13/2009 | CA2714506A1 Composition for sustained release delivery of proteins or peptides |
| 08/13/2009 | CA2714505A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 08/13/2009 | CA2714231A1 Topical antimicrobial compositions |
| 08/13/2009 | CA2714200A1 Method for improving storage stability of glutathione |
| 08/13/2009 | CA2714113A1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols |
| 08/13/2009 | CA2714112A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
| 08/13/2009 | CA2714082A1 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 08/13/2009 | CA2714015A1 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| 08/13/2009 | CA2714006A1 Stabilized protein compositions |
| 08/13/2009 | CA2713438A1 Treatment of bladder diseases with a tlr7 activator |
| 08/13/2009 | CA2713386A1 Liquid formulation of fsh |
| 08/13/2009 | CA2713380A1 Compositions of phytosterols with enhanced bioavailability |
| 08/13/2009 | CA2713361A1 Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-iv inhibitor |
| 08/13/2009 | CA2711974A1 Edible film-strips with modified release active ingredients |